Viridian Therapeutics
VRDN
VRDN
9 hedge funds and large institutions have $1.22M invested in Viridian Therapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$126K | |
| 2 | +$66K | |
| 3 | +$24K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$22K |
| 5 |
FNYS
First New York Securities
New York
|
+$9.86K |
Top Sellers
| 1 | -$186K | |
| 2 | -$56K | |
| 3 | -$51K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$34K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17K |